J
Jaehwi Lee
Researcher at Chung-Ang University
Publications - 158
Citations - 4657
Jaehwi Lee is an academic researcher from Chung-Ang University. The author has contributed to research in topics: Kinase & Tumor necrosis factor alpha. The author has an hindex of 31, co-authored 156 publications receiving 3913 citations.
Papers
More filters
Journal ArticleDOI
Preclinical Pharmacokinetic Evaluation of β-Lapachone: Characteristics of Oral Bioavailability and First-Pass Metabolism in Rats
Iksoo Kim,Hyeongmin Kim,Jieun Ro,Kanghee Jo,Sandeep Karki,Prakash Khadka,Gyiae Yun,Jaehwi Lee +7 more
TL;DR: It is suggested that the fairly low oral bioavailability of β-lapachone may be resulted from the first-pass metabolic degradation of α- Lapachone in the liver, small and large intestinal tracts and its low aqueous solubility.
Journal ArticleDOI
A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets.
Jun Sang Park,Ji Yeon Shim,Nguyen Khoa Viet Truong,Jung Soo Park,Sangmun Shin,Young Wook Choi,Jaehwi Lee,Jeong-Hyun Yoon,Seong Hoon Jeong +8 more
TL;DR: PEG rate of about 90-150% is suggested for matrix tablet formulations, and the exact ratio could be formulated according to the resulting tablet's properties.
Journal ArticleDOI
p38/AP-1 Pathway in Lipopolysaccharide-Induced Inflammatory Responses Is Negatively Modulated by Electrical Stimulation
TL;DR: Results suggest that ACP-induced nanocurrents alter signal transduction pathways that are involved in the inflammatory response and could therefore be utilized in the treatment of various inflammatory diseases such as arthritis and colitis.
Journal ArticleDOI
Cell-permeable ceramides act as novel regulators of U937 cell-cell adhesion mediated by CD29, CD98, and CD147.
TL;DR: Novel modulatory effects of ceramides on the functional activation of beta1 integrins (CD29) and their associated molecules are reported, using U937 cell-cell or cell-fibronectin (FN) adhesion events, to suggest a novel possibility that ceramide can be used as a therapeutic drug regarding CD29-mediated pathological events.
Journal ArticleDOI
Cafestol, a coffee-specific diterpene, is a novel extracellular signal-regulated kinase inhibitor with AP-1-targeted inhibition of prostaglandin E2 production in lipopolysaccharide-activated macrophages.
TL;DR: The data suggest that cafestol may be a novel ERK inhibitor with AP-1-targeted inhibitory activity against PGE(2) production in LPS-activated RAW264.7 cells.